FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approval of Meitheal Pharmaceuticals' original ANDA for Cytarabine (cytarabine), a generic injectable anticancer agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

ORIG AP for CYTARABINE (CYTARABINE)